Home
Conditions
Dyskinesia, Drug-Induced

Clinical trial condition

Dyskinesia, Drug-Induced

Explore clinical trials studying Dyskinesia, Drug-Induced. Study availability and eligibility vary by location and protocol.

44 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Dyskinesia, Drug-Induced trial results

Completed

A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia

NCT02274558

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Little Rock, Arkansas, United States

Anaheim, California, United States

Glendale, California, United States

Irvine, California, United States

View all 54 locations

View Trial Details

Completed

The Assessment of Movement Disorders Utilizing Live Two-Way Video

NCT01467089

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +9 more
Locations: The Zucker Hillside Hospital Glen Oaks, New York, United States

View Trial Details

Completed

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

NCT01391390

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +9 more
Locations: Beijing HuiLongGuan hospital Beijing, China

View Trial Details

Completed

Levetiracetam Treatment of Tardive Dyskinesia

NCT00291213

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Connecticut Mental Health Center New Haven, Connecticut, United States

View Trial Details

Completed

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

NCT00401089

Conditions: Body Weight, Central Nervous System Diseases, Dyskinesia, Drug-Induced, +21 more
Locations: Queen's University Kingston, Ontario, Canada

Regional Mental Health Care London St. Thomas, Ontario, Canada

Northern Ontario Medical School Thunder Bay, Ontario, Canada

Northwick Park Hospital Harrow, Middlesex, United Kingdom

View Trial Details

Completed

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

NCT01176721

Conditions: Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +28 more
Locations: Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universitaet Muenchen Munich, Bavaria, Germany

Departement of Psychiatry and Psychotherapy, University Hospital of Goettingen Göttingen, Lower Saxony, Germany

View Trial Details

Completed

Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia

NCT01267188

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Toronto, Ontario, Canada

View Trial Details

Completed

Piracetam for Treatment Tardive Dyskinesia

NCT00190008

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Beersheva Mental Health Center Beersheva, Israel

View Trial Details

Completed

Tardive Dyskinesia and Cognitive Function

NCT00926965

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +7 more
Locations: Yu-Li Veternas Hospital Hualien City, Taiwan

View Trial Details

Completed

Extract of Ginkgo Biloba and Tardive Dyskinesia

NCT00672373

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +9 more
Locations: Beijing Hui-Long-Guan Hospital Beijing, China

View Trial Details

Dyskinesia, Drug-Induced

Dyskinesia, Drug-Induced trial results

Related conditions